Survival outcomes and toxicity of adjuvant immunotherapy after definitive concurrent chemotherapy with proton beam radiation therapy for patients with inoperable locally advanced non-small cell lung carcinoma

CONCLUSION: This study, one of the first to investigate CPBT followed by IO for inoperable LA-NSCLC, showed that IO conferred survival benefits with no increased rates of toxicity.PMID:38311031 | DOI:10.1016/j.radonc.2024.110121

Source: Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology - February 4, 2024 Category: Radiology Authors: Kelsey L Corrigan Ting Xu Yuki Sasaki Ruitao Lin Aileen B Chen James W Welsh Steven H Lin Joe Y Chang Matthew S Ning Saumil Gandhi Michael S O'Reilly Carl M Gay Mehmet Altan Charles Lu Tina Cascone Efstratios Koutroumpakis Ajay Sheshadri Xiaodong Zhang Li Source Type: research